chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Throwing up; Stomach burn; Didn't feel good; tired; Sore left arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSPEPSIA (Stomach burn), MALAISE (Didn't feel good), VOMITING (Throwing up), FATIGUE (tired) and VACCINATION SITE PAIN (Sore left arm) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021B21A and 002A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CURCUMA LONGA (TURMERIC CURCUMIN [CURCUMA LONGA]) for Nutritional supplement, VITAMIN C [ASCORBIC ACID] and MESO ZEAXANTHIN, XANTOFYL, ZEAXANTHIN (MACUHEALTH WITH LMZ3) for Supplementation therapy, MULTIVITAMIN [VITAMINS NOS] for an unknown indication.   On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Apr-2021, the patient experienced FATIGUE (tired) and VACCINATION SITE PAIN (Sore left arm). On 30-Apr-2021, the patient experienced DYSPEPSIA (Stomach burn) and MALAISE (Didn't feel good). On 30-Apr-2021 at 8:45 PM, the patient experienced VOMITING (Throwing up). At the time of the report, DYSPEPSIA (Stomach burn), MALAISE (Didn't feel good), VOMITING (Throwing up), FATIGUE (tired) and VACCINATION SITE PAIN (Sore left arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.   This case was linked to MOD-2021-059462 (Patient Link).
Area of swelling and itching around injection site that began 9-10 days after injection. The patch is about 3x4or 5 inches
PT SAID HER BLOOD PRESSURE ROSE TO 220/130 1 HOUR AFTER VACCINATION . PT WENT TO ER AND THEY STABALIZED HER AND SENT HER HOME. NO PRIOR BP PROBLEMS PER PATIENT
On the 4th day following the vaccine, patient suddenly became extremely weak, unable to do smallest of activities which were easy to perform before.  Could not get up from toilet, chair, etc.  Unable to get into vehicle without assistance.  Unable to walk without walker and assistance.  Prior to day 4 after vaccine, completely able to live independently, preparing meals, doing minor housework, get into and out of chair, on and off of toilet, etc.  Patient was moved to daughter's home, and homecare was set up.  After visit to cardiologist and various tests, she was diagnosed with afib and congestive heart failure; was taken off of all blood pressure meds as now blood pressure was suddenly low.  Condition continued to deteriorate, and placed on hospice care.  Died five weeks later.
The next day I was pretty much wiped out. I was having trouble breathing. 2 weeks after getting the shot I went to see the doctor I was prescribed ventalin because they thought it was seasonal allergies. It didn't get any better so I went back to the doctor and I was referred to a cardiologist. It continued to get worse. The cardiologist has now taken over and have ran stress test.
Pt received varicella vaccine-immediately after developed facial edema, coughing and c/o throat discomfort, lungs with good BS, but mild wheeze, given-Benadryl 25 mg IM, albuterol via nebulizer with 5C Oz epinephrine 0.3 cc SQ EMS called-Pt to ER for observation/treatment management
Pt reports day 1 post vaccination fever, throat tightness; diffiuclty swallowing; difficulty breathing "a little"; dizziness; lightheadedness. Pt sent to ER
24 hours after vaccination patient complains of arthralgias, fatigue, headache.  36 hours after vaccination complained of macular rash on the left breast above the areola.  Seen in clinic on March 10,  macular confluent erythema 9 x 5 cm, no induration,  no pruritis, mild swelling, c/ pain in left axillary area.  No nipple discharge. Afebrile.  No adenopathy.  BP 121/78, pulse 72, Resp. 17, T 36.1 C, Sat 91%.  z
Baby became dusky after Hep B. administration. Repeated episode one time. Arterial saturation droppped to 84-85% with second episode. Tx with blowky oxygen and admitted to hospital.
had an allergic reaction to it; now she is having constant pain; "it's hard"; This spontaneous report was received from the 80-year-old female patient, who refers to herself. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, the patient was vaccinated with pneumococcal vaccine (manufacturer unknown) [not reported, if it was pneumococcal vaccine, polyvalent (23-valent) or pneumococcal 15v conj vaccine (crm197)] (dose number, strength, lot #, expiry date, and route of administration and anatomical location were not provided) for prophylaxis.  On an unknown date, the patient experienced an allergic reaction to the vaccine, she had a constant pain, and reported, that "it is hard" (ill-defined disorder). The outcome of the events was unknown.   The reporter considered event of an allergic reaction to be related to the suspect therapy and the relatedness was unknown regarding to the other events.
Called patient today on Thursday 5/20 as error noted in system. Pt.called at home in a.m. of 5/20/2021 and counseled for error. No side effects noted by Patient today. Pt. first dose Moderna on 4/21/2020 lot # 009C21A.
Patient developed redness of Rt thigh 5 days (04/27/2002) after receiving immunizations on 4/22/02. Admitted to hospital 4/28/02 - 5/3/02 for antibiotic treatment of cellulitis of right lower extremity and acute otitis media.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. In April 2016, the patient was inoculated with ZOSTAVAX (lot number, dosage and route of administration not provided), as recommended for routine adult health maintenance and for the prevention of shingles. The zoster vaccine live ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. Later in 2016, the patient was treated for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome is unknown. Additional information has been requested.
arm pain; fever 103.6; headache; chills; intermittent fever; fatigue; cough; labored breathing; This is a spontaneous report from a non-contactable Nurse (patient). A 54-years-old non pregnant female patient received BNT162B2 (COVID-19 vaccine, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route, administered in Left Arm on 14Apr2021 at 09:00 (at the age of 54-years-old) as dose 2, single for covid-19 immunisation. The patient was not pregnant at the time of vaccination. Medical history included covid-19 and Known allergies of Roxicet from an unknown date and unknown if ongoing. Concomitant medication(s) (Other medications in two weeks) included levothyroxine 25 mcg (LEVOTHYROXINE) taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 as dose 1 single on 24Mar2021 at 20:30 in Left Arm for covid-19 immunisation and experienced, pain in extremity, headache, fever 100.7, chills-intermittent fever and fatigue between vaccinations. Facility type vaccine other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 post vaccination. On 14Apr2021 at 18:00 the patient experienced arm pain, fever 103.6, headache, chills, intermittent fever, fatigue, cough and labored breathing. The patient underwent lab tests and procedures which included body temperature: 100.7, intermittent fever and fatigue between vaccinations on an unspecified date and body temperature: 103.6 on 14Apr2021. No treatment received for the events. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
mom reported p/pt recv vax 6FEB97 exp inc temp of 104 & given APAP & prolonged high pitched, inconsolable crying;sx cont x 3 days;taken to ER 9FEB97 & was seen by MD who recommended pt only have DT dx immun rxn;
My arm was very swollen from the injection site to my fingers, pretty sore and I had a bit of a rash on my right arm. Nauseous, felt like I was going to pass out. Fatigued.
hasn't slept all night; Itching; This is a spontaneous report from a contactable consumer (patient).  An 84-year-old female patient received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, lot number unknown and has been requested), via an unspecified route of administration on 10Jan2021 at single dose because COVID is getting worse and she is in a home. Medical history included 17 back surgeries, has lost a good bit of weight, ongoing pain, ongoing arthritis and ongoing sleep disorder.  Concomitant medication included hydrocodone bitartrate, paracetamol (manufacturer unknown) from an unknown date and unknown if ongoing and morphine pump (manufacturer unknown) for pain which she has had for eight years that is right under the skin. The patient was also taking something (unspecified) for arthritis and they give her something (unspecified) to help her sleep. The patient got her first shot on Sunday, 10Jan2021. She has not had effects or anything. However on 13Jan2021, she started itching. She stated that honest to God she hasn't slept all night on an unspecified date. She is itching all over. She wanted to know if this was something that comes with the vaccine. She thought if she would have something it would have happened on Monday or Tuesday and at the time of the report it was Thursday. She stated that she was not that concerned. She was just calling to pass this along. She added that she is in good shape structurally. She was not worried as someone might have the same effect. This could just be side effects.  The outcome of the event itching was recovering while the outcome of the event hasn't slept all night was unknown.   Information on the Batch/Lot number has been requested.
Redness, itchy, painful area of injection site that has lasted over 2 months.
Pt started with pain in her right deltoid area, 36 hours, post vax. Today, woke up with an area of warmth, erythema and decreased ROM, with induration in the center. Area 10cm. Started pt on Keflex.
I started having lumpy feeling in my throat. GI cramps, and diarrhea and my knee flared up as well.
swollen lips that last 3 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of LIP SWELLING (swollen lips that last 3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (swollen lips that last 3 days). At the time of the report, LIP SWELLING (swollen lips that last 3 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided. Patient due for their second injection tomorrow.   Reporter did not allow further contact
This spontaneous report as received from a pharmacist refers to a 72 year old female patient with hypertension and none drug reactions or allergies. On an unknown date the patient was vaccinated with PNEUMOVAX 23 (in the arm, intramuscular, lot # K006681, expiration date: 21-OCT-2015). Concomitant medications included unspecified medication for hypertension. On 20-SEP-2014, after receiving PNEUMOVAX 23 the patient's upper arm became swollen and red at the injection site, down to her elbow and that she also felt sick after receiving PNEUMOVAX 23. None lab diagnostics studies were performed. The patient sought medical attention via calling the pharmacy. The pharmacist requested a lot check for PNEUMOMVAX 23 (lot # K006681, expiration date: 21-OCT-2015) and requested a call back regarding the results of the lot check. The outcome of events was reported as recovering. The relatedness between events and PNEUMOVAX 23 was not reported. This is one of several reports from the same reporter. Additional information has been requested.
Patient returned to pharmacy reporting itching and rash near the site of injection on the first day and induration at the site on the second and third day. The site of injection is hardened, swollen and warm to touch. She reports slight improvement from the previous day. The patient acknowledges taking ALLEGRA and reports no stomach pain or other signs of allergic reaction. Patient reports that she has an egg allergy (If baked in food okay to eat, but if hard boiled then it causes stomach pain).
Thrombotic stroke LMCA Embolic CVA; TPA;  LICA thrombus - mechanical throbectoomy
MASSIVE HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced massive headache. Treatment medications (dates unspecified) included: ibuprofen. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from massive headache. This report was non-serious.
Tingling on left side of the face; Weird thinking; Weird dreams; Heavy foot feeling; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety. Concomitant products included CLONAZEPAM (KLONOPIN) for Anxiety, LEVOTHYROXINE SODIUM (SYNTHROID), VENLAFAXINE HYDROCHLORIDE (EFFEXOR), AMLODIPINE BESILATE (NORVASC), LOSARTAN and OMEPRAZOLE MAGNESIUM (PRILOSEC [OMEPRAZOLE MAGNESIUM]) for an unknown indication.    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Jan-2021, the patient experienced PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking), ABNORMAL DREAMS (Weird dreams) and LIMB DISCOMFORT (Heavy foot feeling). The patient was treated with PARACETAMOL (TYLENOL) for product used for unkown indication, at an unspecified dose and frequency. On 25-Jan-2021, PARAESTHESIA (Tingling on left side of the face), FEELING ABNORMAL (Weird thinking) and ABNORMAL DREAMS (Weird dreams) had resolved. At the time of the report, LIMB DISCOMFORT (Heavy foot feeling) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-021655 (Patient Link).
Information has been received from a registered nurse concerning a 12-month-old female with restrictive airway disease, and no history of drug reactions or allergies, who on 19-DEC-2006 was vaccinated with one 0.5 ml subcutaneous dose of Varivax (Lot # 654025/0802F) in the left thigh. Concomitant medication included a first Vaqta Lot # 656495/1029F) in the left thigh and a third Prevnar (Lot # B08646K). There was no illness at the time of vaccination. On 31-DEC-2006, she became "cranky," and, on 02-JAN-2007 the patient experienced a varicella rash with approximately 15 lesions in different stages on her trunk. There were no laboratory or diagnostic studies performed. Outcome was reported as recovered. No additional information to report. There was no product quality complaint. There were no adverse events following prior vaccinations. No additional information is expected.
Information has been received from a health professional concerning a patient was vaccinated with one dose of vaccine. The patient was titered on 01/17/2001 and showed failure to seroconvert. The patient sought unspecified medical attention. Addiitonal information has been requested.
Customer came to get the covid booster . She was given flu shot instead of covid  vaccine. The customer was with her daughter who was getting a fu shot. The customer was given  flu shot accidently . The customer already got another flu shot in another pharmacy 2 weeks before.
Information has been received from a physician concerning a 16-year-old white female student, with no known relevant medical history nor drug allergy, who on 15-JAN-2007 was vaccinated IM in her left deltoid with the first dose of GARDASIL (lot # 653650/0697F).  Concomitant therapy included ALESSE, ASTELIN and RHINOCORT.  On 26-FEB-2007, the patient experienced headache and myalgia.  On 27-FEB-2007, her temperature was 101 degrees Fahrenheit.  Medical attention was sought and the events required ER/DR visit.  Laboratory test showed that all CBC and ESR were negative.  On 23-MAR-2007, the patient was vaccinated IM in her left deltoid with the second dose of GARDASIL (lot # 653650/0697F).  Subsequently on 24-MAR-2007, she experienced "ST" and headache.  On 26-MAR-2007, her temperature was of 101.5 degrees Fahrenheit, she also experienced bodyache.  The patient's outcome was unknown.  No further information is available.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. No concurrent conditions, medical history and concomitant medications were reported. Approximately in 2016 (reported as from 24-MAR-2016 to 01-APR-2016) multiple unspecified patients were vaccinated with improperly stored MMR II lot#L027591, expiry: 23-JUL-2017 (dosing details were not reported). The patients sought medical attention. It was reported that the vaccines were exposed to maximum temperature of 9.9C and minimum temperature of 0.8C during a time frame of 2 hours. No previous temperature excursion was reported. No adverse effect was reported. There were no product quality complaints (PQC) involved. This is one of several reports received from the same reporter. Additional information has been requested.
While checking inventory that Pediarix was documented as given, but vaxelis was actually adminstered; This non-serious case was received during the Vaccines Adverse Event Reporting System (VAERS) monitoring on 12-JUL-2022 with the following VAERS Primary ID 2312794-1. The original narrative from the sender is the following:  No adverse reaction was reported. It was discovered on 6/1/2022 while checking inventory that Pediarix was documented as given, but Vaxelis was actually administered.  Baby received 2 doses of Hib in error. Mother/guardian of child was telephoned on 6/1/2022, at number provided in patient's record, but message "not accepting calls" was received. Her voice mail box was full, so no message was left.
Sore and swollen arm at injection site.5 days still swollen, not as sore, swelling not going down.
Information has been received from a physician concerning a 5 yr old female who, on 31Mar05, was vaccinated with a 0.5ml dose of varicella virus vaccine live (lot648948/0895P). It was reported that 14 days later the pt developed ataxia. Unspecified medical attention was sought. No product quality complaint was involved. Follow up information from a physician indicated that the pt showed symptoms on 18Apr05. She went to the ER on that day, and a CT scan was done. Lab work was performed on 19Apr05. On 21Apr05 the physician informed the mother the pt had ataxia. By 25Apr05 the pt was recovered. Additional information has been requested.
Pt developed redness and induration at the site of DTAP injection, 20 hours, post vax. He was seen at youth care on 7/20/01. No Rx. Advised Tylenol. On 7/23/01, had an area of redness increasing to 9cm and a rash of red bumps appeared under arm and left side of face. He was seen at youth care and advised it was a reaction to the pertussis. He was given: Oropred, Cephalexin and Hydroxyz HCL.
10:03AM Light headed, flushed, chest tightness.  BP 138/84, HR 92, SPO2 98%.  Pt placed in supine position. VS monitored. Fluids given.  PT AOPPT.  10:10AM BP 103/70, HR 83, SPO2 97%.  10:223AM BP 150/95, HR 97, SPO2 100%.  10:40AM BP 138/91, HR 98, SPO2 100%
2 weeks post injection the injection site is warm to the touch, slightly discolored (red / gray?) and puffy.  If I press on it there's still a good amount of pain.
Patient stated her arm was extremely hot, burning, extremely swollen down to just above her elbow and sore- it hurt to even put a bed sheet over her arm. She also couldn't lift her arm over her head. These symptoms lasted for several days and have improved but she still has some lingering arm pain.
Rash; Hives/broke out in an urticarial hive/raised welts; Inappropriate schedule of vaccine; This case was reported by a physician via call center representative and described the occurrence of rash in a 4-month-old patient who received HBV (Engerix B) for prophylaxis.   Co-suspect products included PNEUMOCOCCAL VACCINE (PREVNAR) for prophylaxis and PENTACEL for prophylaxis.   On an unknown date, the patient received the 2nd dose of Engerix B, PREVNAR at an unknown dose and PENTACEL at an unknown dose. On an unknown date, less than a year after receiving Engerix B, the patient experienced rash, hives and drug dose administration interval too long. On an unknown date, the outcome of the rash and hives were recovered/resolved and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the rash and hives to be related to Engerix B.  Additional details were received as follows: MD reported that a 4 month old received the second dose of Hep B 4 months after the first dose was received as a newborn.  Second dose of Hep B was administered at the MD's office. This led to lengthening of vaccination schedule. The physician stated that he is not certain of the vaccine used for the first dose, unsure of the vaccine used for the second dose, but he was pretty sure that the second dose was Engerix-B.  After the infant received the Hep B vaccination, they broke out in an urticarial hive rash around the back of its neck and behind its ear, raised welts.  The rash lasted a couple of days, infant is doing fine now.  Infant also received Pentacel and Prevnar. Physician was not at the office, unable to provide vaccine name or lot/exp, no patient information available. The reporter consented to follow up.
Patient experienced pruritis over her entire body.  It began with her feet then spread to her arms, trunk, legs.  The episode lasted 2 to 3 hours.  Patient took 50mg benadryl and went to bed.  Itching resolved upon waking but patient's left arm was sore and she had myalgia, which resolved in 12 hours.